This site is intended for Healthcare professionals only.

Impose price cap on 19 medical devices notified as drugs : Industry body to NPPA

Impose price cap on 19 medical devices notified as drugs : Industry body to NPPA

The associations asked NPPA to

– first and foremost publish data on the trade margins involved in medical devices notified as ‘drugs’ under the Drugs and Cosmetics Act and Rules falling in 19 categories that remain outside the purview of price regulation, and
– act without further delay to impose price caps as the only appropriate and sustainable measure to ensure affordability of these critical devices.

Responding to the announcement by All India Syringes and Needles Manufacturers Association (AISNMA) to voluntarily reduce trade margins to 75% on ex-factory prices, All India Drug Action Network (AIDAN) has called upon the NPPA to impose price caps on medical devices notified as ‘drugs’ under the Drugs and Cosmetics Act and Rules falling in 19 categories that currently remain outside the purview of price regulation.

Welcoming the decision of the syringe and needle manufacturers to reduce prices, AIDAN states that self-regulation has never been an effective solution and often compromises transparency.

“This initiative is a voluntary action by a group of Indian manufacturers to cut prices and its success depends on the willingness of all manufacturers to conform to the proposed reduction in trade margins and set lower MRPs. At the moment, not all the companies particularly the multinational companies are part of the initiative” said the statement.

It is a well-known fact that it is the private institutional buyers that are taking maximum advantage of high MRPs to reap big profits. These players can still force manufacturers or a section of them to continue business per usual, at the expense of consumers. Such a scenario would be avoided under government regulation that applies uniformly to all manufacturers.

Because of the misalignment of business interests with patient welfare, regulation in healthcare exists as the norm rather than exception around the world. The government has a constitutional obligation to protect people from the exploitation of third parties and therefore needs to intervene to ensure affordability of medical devices, AIDAN said in a statement.

Self-regulation does not guarantee compliance and cannot be enforced. Regulation is essential for enforcement and also works in favor of the long-term health of the domestic industry by ensuring a level-playing field is maintained across manufacturers.

AIDAN statement said, “Therefore, we call upon the NPPA to first and foremost publish data on the trade margins involved in medical devices notified as ‘drugs’ under the Drugs and Cosmetics Act and Rules falling in 19 categories that remain outside the purview of price regulation; and act without further delay to impose price caps as the only appropriate and sustainable measure to ensure affordability of these critical devices.”

Source: With Agency Inputs
3 comment(s) on Impose price cap on 19 medical devices notified as drugs : Industry body to NPPA

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. Tab CIPCAL 500mg from CIPLA MRP 65/- Price to retail medical shop Rs 8/- . CIPLA is helping the Retail Medical shops and Quacks (called as RMP and PMP in Andhra Pradesh) earn more than 2 lakhs per month with high trade margin on vitamins, antiulcer drugs like pantoprazole etc. Please search website pmpassociationofindia, call the mobile number and take details about their registration number of society, constitution, byelaws etc. Also visit their facebook page. Take help of telugu translator. They give inj diclofenac and inj dexamethasone (steroid) and charge Rs 100 to 200 for 2 injections instead of Tab Paracetmol 500 mg 6th hrly which costs 4 Rs for 4 tab. They rob the poor. Please Visit Kurnool Medical College and know about the antiquack movement in Andhra Pradesh

  2. Tab CIPCAL 500mg from CIPLA MRP 65/- Price to retail medical shop Rs 8/- . CIPLA is helping the Retail Medical shops and Quacks (called as RMP and PMP in Andhra Pradesh) earn more than 2 lakhs per month with high trade margin on vitamins, antiulcer drugs like pantoprazole etc. Please search website pmpassociationofindia, call the mobile number and take details about their registration number of society, constitution, byelaws etc. Also visit their facebook page. Take help of telugu translator. They give inj diclofenac and inj dexamethasone (steroid) and charge Rs 100 to 200 for 2 injections instead of Tab Paracetmol 500 mg 6th hrly which costs 4 Rs for 4 tab. They rob the poor. Please Visit Kurnool Medical College and know about the antiquack movement in Andhra Pradesh

  3. Tab CIPCAL 500mg from CIPLA MRP 65/- Price to retail medical shop Rs 8/- . CIPLA is helping the Retail Medical shops and Quacks (called as RMP and PMP in Andhra Pradesh) earn more than 2 lakhs per month with high trade margin on vitamins, antiulcer drugs like pantoprazole etc. Please search website pmpassociationofindia, call the mobile number and take details about their registration number of society, constitution, byelaws etc. Also visit their facebook page. Take help of telugu translator. They give inj diclofenac and inj dexamethasone (steroid) and charge Rs 100 to 200 for 2 injections instead of Tab Paracetmol 500 mg 6th hrly which costs 4 Rs for 4 tab. They rob the poor. Please Visit Kurnool Medical College and know about the antiquack movement in Andhra Pradesh